Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA, THEMIS Steering Committee and Investigators

Open source

DOI: 10.1016/s0140-6736(19)31887-2
Published: 2019 Sep 28
Container: Lancet (London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-19-31887-2,
  title = {Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.},
  author = {Bhatt DL and Steg PG and Mehta SR and Leiter LA and Simon T and Fox K and Held C and Andersson M and Himmelmann A and Ridderstråle W and Chen J and Song Y and Diaz R and Goto S and James SK and Ray KK and Parkhomenko AN and Kosiborod MN and McGuire DK and Harrington RA and THEMIS Steering Committee and Investigators},
  year = {2019},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(19)31887-2},
  url = {https://doi.org/10.1016/s0140-6736(19)31887-2}
}

RIS

TY  - JOUR
TI  - Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.
AU  - Bhatt DL
AU  - Steg PG
AU  - Mehta SR
AU  - Leiter LA
AU  - Simon T
AU  - Fox K
AU  - Held C
AU  - Andersson M
AU  - Himmelmann A
AU  - Ridderstråle W
AU  - Chen J
AU  - Song Y
AU  - Diaz R
AU  - Goto S
AU  - James SK
AU  - Ray KK
AU  - Parkhomenko AN
AU  - Kosiborod MN
AU  - McGuire DK
AU  - Harrington RA
AU  - THEMIS Steering Committee and Investigators
PY  - 2019
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(19)31887-2
UR  - https://doi.org/10.1016/s0140-6736(19)31887-2
ER  -

APA

DL, B., PG, S., SR, M., LA, L., T, S., K, F., C, H., M, A., A, H., W, R., J, C., Y, S., R, D., S, G., SK, J., KK, R., AN, P., MN, K., DK, M., RA, H., & Investigators, T. S. C. A. (2019). Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(19)31887-2

Source records

pubmed · retrieved 2026-09-26T07:55:30.915Z